BMS chief wins big pay hike following R&D success; Organogenesis wins OK for new therapy; Epistem inks pact with GSK;

@FierceBiotech: Beefed-up aspirin, charged with gas, conquers colon cancer in lab. Item | Follow @FierceBiotech

@JohnCFierce: Hwang Woo-Suk is an oddly compelling character. Convicted in a scandal that would have destroyed anyone, still moving on. Story | Follow @JohnCFierce

@RyanMFierce: FDA advisers back J&J, Pfizer efforts to start testing controversial arthritis pain meds. Story | Follow @RyanMFierce

@FierceMedDev: Consumer Reports taps ire over bad medical devices. News | Follow @FierceMedDev

> Bristol-Myers Squibb ($BMY) chief Lamberto Andreotti is benefiting from the biotech's successful R&D work. The CEO won a 27% increase in total compensation last year, earning $14.9 million. Story

> Organogenesis has won approval for Gintuit, which spurs the development of new gum tissue. Report

> The U.K.'s Epistem has inked a fibrosis research pact with GlaxoSmithKline ($GSK). Report

Pharma News

@FiercePharma: So why would Pfizer walk away from its $200M upfront for the Biocon diabetes deal? Item | Follow @FiercePharma

> Feds reportedly demand $1.8B in Risperdal marketing probe. Item

> After big hike in 2011, GSK CEO's pay set to jump again. News

> AstraZeneca sues FDA to block Seroquel copies. Report

> Pfizer's marketing pact with Biocon falls apart. More

Biotech Research News

> Stem cells end need for anti-rejection meds in some kidney transplant patients. Item

> U.K. research knocks wind out of personalized medicine push. Report

> Antibody blocks advance of Alzheimer's plaque in mice. Story

> Glaucoma-stricken rats see better, thanks to stem cells. Article

> Beefed-up aspirin, charged with gas, conquers colon cancer in lab. News

> RhoGDI2 protein hampers bladder cancer metastasis. Story

Manufacturing News

> Fire at Sandoz plant complicates drug shortages. Item

> Litigation: Sanofi, Genzyme 'negligently allowed a virus contamination in the manufacturing facility.' News

> Loss of manufacturing contract takes toll on Patheon. Report

> U.K. drug regulator asks industry to name the rules it wants to go. Story

> FDA says 5 years of Warner Chilcott's Ovcon BC pills suspect. Item

> WHO joins agencies in beefing up inspections of API facilities. Article

And Finally… Disgraced South Korean scientist Hwang Woo-Suk has enlisted in an effort to clone the woolly mammoth, which has been extinct for thousands of years. Story

Suggested Articles

Reata’s bardoxolone improved kidney function in a phase 3 trial of patients with a rare form of chronic kidney disease.

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.